|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Colorectal Cancer - Lifestyle risk factors and population dynamics drive incident cases
Datamonitor, Oct 2011, Pages: 51
Over the past 3 decades, the incidence of colorectal cancer has increased in low incidence countries but stabilized in high incidence countries. However, in the seen major markets, aging populations, rising physical inactivity, and overweight ensure growth in colorectal cancer patient populations. Indeed, between 2010 and 2020, both incident and prevalent cases will increase.
Features and benefits
- Gain insights into the estimates and forecast of incident colon and rectal cancer cases in the US, Japan, France, Germany, Italy, Spain, and the UK.
- Understand the stage distribution of newly diagnosed colorectal cancer in these markets.
- Gain insights into the possible underlying risk factors driving the epidemiology of colorectal cancer in the seven major markets.
Highlights
- In 2010, there were 375,400 people diagnosed with colon cancer in the seven major markets. Colon cancer diagnoses will increase by 21.6% to 456,500 in 2020. In 2010, the US, the five major EU markets, and Japan had 125,900, 81,200, and 168,300 incident cases, respectively.
- In 2010, there were 182,700 people diagnosed with rectal cancer in the seven major markets. Rectal cancer diagnoses will increase by 17% to 213,400 in 2020. In 2010, the US, the five major EU markets, and Japan had 54,700, 89,000, and 38,900 incident cases, respectively.
- Datamonitor estimates that prevalent cases of colon and rectal cancer will continue to increase in the seven major markets. In 2010, there were approximately 1.3 million and 598,900 prevalent cases of colon and rectal cancer cases, respectively. By the end of 2020, there will be about 1.58 million prevalent colon and 743,700 rectal cancer cases.
Your key questions answered
- What are the most robust sources for colorectal cancer incidence data?
- What is the current patient population of colorectal cancer in the seven major markets?
- How will the colorectal cancer patient population change over the next decade in the US, Japan, France, Germany, Italy, Spain, and the UK?
- How do changes in the population structure and the risk factors affect the trends in incident colorectal cancer cases?
|
|
|
|
